97 related articles for article (PubMed ID: 3856479)
1. Coagulopathy induced by continuous infusion of high doses of human lymphoblastoid interferon.
Mirro J; Kalwinsky D; Whisnant J; Weck P; Chesney C; Murphy S
Cancer Treat Rep; 1985 Mar; 69(3):315-7. PubMed ID: 3856479
[TBL] [Abstract][Full Text] [Related]
2. Phase I-II study of continuous-infusion high-dose human lymphoblastoid interferon and the in vitro sensitivity of leukemic progenitors in nonlymphocytic leukemia.
Mirro J; Dow LW; Kalwinsky DK; Dahl GV; Weck P; Whisnant J; Murphy SB
Cancer Treat Rep; 1986 Mar; 70(3):363-7. PubMed ID: 3456833
[TBL] [Abstract][Full Text] [Related]
3. Phase I study of weekly high-dose human lymphoblastoid interferon.
Connors JM; Silver HK
Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose methotrexate on the hemostatic system in childhood acute lymphoblastic leukemia.
Totan M; Dagdemir A; Ak AR; Albayrak D; Kucukoduk S
Med Pediatr Oncol; 2001 Apr; 36(4):429-33. PubMed ID: 11260565
[TBL] [Abstract][Full Text] [Related]
5. Blood coagulopathy in dogs with shock induced by injection of heartworm extract.
Kitoh K; Watoh K; Kitagawa H; Sasaki Y
Am J Vet Res; 1994 Nov; 55(11):1542-7. PubMed ID: 7879977
[TBL] [Abstract][Full Text] [Related]
6. Prospectively randomized toxicity study of high-dose versus low-dose treatment strategies for lymphoblastoid interferon.
Silver HK; Connors JM; Salinas FA
Cancer Treat Rep; 1985; 69(7-8):743-50. PubMed ID: 4016785
[TBL] [Abstract][Full Text] [Related]
7. [Blood coagulation changes in children with acute myelogenous leukemia: thrombin effect or proteolysis].
von Kries R; Ebell W; Jürgens H; Göbel U
Klin Padiatr; 1984; 196(3):174-7. PubMed ID: 6590923
[TBL] [Abstract][Full Text] [Related]
8. Coagulation factor analysis in patients on long-term anticoagulation.
Perkins HA; Biben RL
Calif Med; 1970 Mar; 112(3):1-7. PubMed ID: 5451608
[TBL] [Abstract][Full Text] [Related]
9. Coagulation studies in leptospirosis.
Jaroonvesama N; Viranuvatti V; Charoenlarp K
Southeast Asian J Trop Med Public Health; 1975 Dec; 6(4):562-6. PubMed ID: 1084021
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
Sarna GP; Figlin RA
Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
[TBL] [Abstract][Full Text] [Related]
11. Acquired coagulopathy owing to parenteral cefamandole: renal failure as a predisposing factor.
Chang JC
Ann Clin Lab Sci; 1983; 13(5):418-24. PubMed ID: 6638932
[TBL] [Abstract][Full Text] [Related]
12. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
Sarna G; Figlin R; McCarthy S
J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous and systemic effects of varying doses of brown recluse spider venom in a rabbit model.
McGlasson DL; Harroff HH; Sutton J; Dick E; Elston DM
Clin Lab Sci; 2007; 20(2):99-105. PubMed ID: 17557708
[TBL] [Abstract][Full Text] [Related]
14. Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safety.
Herring SW; Abildgaard C; Shitanishi KT; Harrison J; Gendler S; Heldebrant CM
J Lab Clin Med; 1993 Mar; 121(3):394-405. PubMed ID: 8445288
[TBL] [Abstract][Full Text] [Related]
15. Coagulation abnormalities in type 1 Gaucher disease in children.
Deghady A; Marzouk I; El-Shayeb A; Wali Y
Pediatr Hematol Oncol; 2006; 23(5):411-7. PubMed ID: 16728361
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma.
Vugrin D; Hood L; Taylor W; Laszlo J
Cancer Treat Rep; 1985; 69(7-8):817-20. PubMed ID: 4016792
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation disorders in childhood].
von Kries R; Göbel U
Monatsschr Kinderheilkd; 1993 Feb; 141(2):137-49. PubMed ID: 8459816
[No Abstract] [Full Text] [Related]
18. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of primary haemostasis in people with neurofibromatosis type 1.
Favaloro EJ; Zafer M; Nair SC; Hertzberg M; North K
Clin Lab Haematol; 2004 Oct; 26(5):341-5. PubMed ID: 15485464
[TBL] [Abstract][Full Text] [Related]
20. Factor XII and other hemostatic protein abnormalities in nephrotic syndrome patients.
Thompson AR
Thromb Haemost; 1982 Aug; 48(1):27-32. PubMed ID: 6813992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
